A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessionbcb1baf1da3fb5dc9a4c71d037e9e0df2384b8ee): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Radiopharmaceutical Solutions Market Research Report 2024

img

Global Radiopharmaceutical Solutions Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Radiopharmaceutical Solutions Market Research Report 2024

According to MRAResearch’s new survey, global Radiopharmaceutical Solutions market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Radiopharmaceutical Solutions market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Radiopharmaceutical Solutions market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


IBA
GE Healthcare
Actinium Pharmaceuticals
Alseres Pharmaceuticals
Cardinal Health
Jubilant Pharma
Central Research Laboratories
Cyclomedica
Bracco
Eckert & Ziegler Radiopharma
Segment by Type
Oral Tracking
Vein Tracking

Segment by Application


Hospitals
Health Systems
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Radiopharmaceutical Solutions report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral Tracking
1.2.3 Vein Tracking
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Solutions Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Health Systems
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Solutions Market Perspective (2018-2033)
2.2 Radiopharmaceutical Solutions Growth Trends by Region
2.2.1 Global Radiopharmaceutical Solutions Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2024-2033)
2.3 Radiopharmaceutical Solutions Market Dynamics
2.3.1 Radiopharmaceutical Solutions Industry Trends
2.3.2 Radiopharmaceutical Solutions Market Drivers
2.3.3 Radiopharmaceutical Solutions Market Challenges
2.3.4 Radiopharmaceutical Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Solutions Players by Revenue
3.1.1 Global Top Radiopharmaceutical Solutions Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Solutions Revenue
3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2022
3.5 Radiopharmaceutical Solutions Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Solutions Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Solutions Breakdown Data by Type
4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2024-2033)
5 Radiopharmaceutical Solutions Breakdown Data by Application
5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Radiopharmaceutical Solutions Market Size (2018-2033)
6.2 North America Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
6.4 North America Radiopharmaceutical Solutions Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Solutions Market Size (2018-2033)
7.2 Europe Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Radiopharmaceutical Solutions Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceutical Solutions Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Solutions Market Size (2018-2033)
8.2 Asia-Pacific Radiopharmaceutical Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Solutions Market Size (2018-2033)
9.2 Latin America Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceutical Solutions Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size (2018-2033)
10.2 Middle East & Africa Radiopharmaceutical Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBA
11.1.1 IBA Company Detail
11.1.2 IBA Business Overview
11.1.3 IBA Radiopharmaceutical Solutions Introduction
11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.1.5 IBA Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction
11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.2.5 GE Healthcare Recent Development
11.3 Actinium Pharmaceuticals
11.3.1 Actinium Pharmaceuticals Company Detail
11.3.2 Actinium Pharmaceuticals Business Overview
11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.3.5 Actinium Pharmaceuticals Recent Development
11.4 Alseres Pharmaceuticals
11.4.1 Alseres Pharmaceuticals Company Detail
11.4.2 Alseres Pharmaceuticals Business Overview
11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.4.5 Alseres Pharmaceuticals Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Detail
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction
11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.5.5 Cardinal Health Recent Development
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Company Detail
11.6.2 Jubilant Pharma Business Overview
11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction
11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.6.5 Jubilant Pharma Recent Development
11.7 Central Research Laboratories
11.7.1 Central Research Laboratories Company Detail
11.7.2 Central Research Laboratories Business Overview
11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction
11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.7.5 Central Research Laboratories Recent Development
11.8 Cyclomedica
11.8.1 Cyclomedica Company Detail
11.8.2 Cyclomedica Business Overview
11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction
11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.8.5 Cyclomedica Recent Development
11.9 Bracco
11.9.1 Bracco Company Detail
11.9.2 Bracco Business Overview
11.9.3 Bracco Radiopharmaceutical Solutions Introduction
11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.9.5 Bracco Recent Development
11.10 Eckert & Ziegler Radiopharma
11.10.1 Eckert & Ziegler Radiopharma Company Detail
11.10.2 Eckert & Ziegler Radiopharma Business Overview
11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction
11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.10.5 Eckert & Ziegler Radiopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Radiopharmaceutical Solutions Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral Tracking
Table 3. Key Players of Vein Tracking
Table 4. Global Radiopharmaceutical Solutions Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Radiopharmaceutical Solutions Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Radiopharmaceutical Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Radiopharmaceutical Solutions Market Share by Region (2018-2023)
Table 8. Global Radiopharmaceutical Solutions Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Radiopharmaceutical Solutions Market Share by Region (2024-2033)
Table 10. Radiopharmaceutical Solutions Market Trends
Table 11. Radiopharmaceutical Solutions Market Drivers
Table 12. Radiopharmaceutical Solutions Market Challenges
Table 13. Radiopharmaceutical Solutions Market Restraints
Table 14. Global Radiopharmaceutical Solutions Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Radiopharmaceutical Solutions Market Share by Players (2018-2023)
Table 16. Global Top Radiopharmaceutical Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2022)
Table 17. Ranking of Global Top Radiopharmaceutical Solutions Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Radiopharmaceutical Solutions Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Radiopharmaceutical Solutions Product Solution and Service
Table 21. Date of Enter into Radiopharmaceutical Solutions Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2018-2023)
Table 25. Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2024-2033)
Table 27. Global Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Radiopharmaceutical Solutions Revenue Market Share by Application (2018-2023)
Table 29. Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Radiopharmaceutical Solutions Revenue Market Share by Application (2024-2033)
Table 31. North America Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Radiopharmaceutical Solutions Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 46. IBA Company Detail
Table 47. IBA Business Overview
Table 48. IBA Radiopharmaceutical Solutions Product
Table 49. IBA Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 50. IBA Recent Development
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Radiopharmaceutical Solutions Product
Table 54. GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Actinium Pharmaceuticals Company Detail
Table 57. Actinium Pharmaceuticals Business Overview
Table 58. Actinium Pharmaceuticals Radiopharmaceutical Solutions Product
Table 59. Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 60. Actinium Pharmaceuticals Recent Development
Table 61. Alseres Pharmaceuticals Company Detail
Table 62. Alseres Pharmaceuticals Business Overview
Table 63. Alseres Pharmaceuticals Radiopharmaceutical Solutions Product
Table 64. Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 65. Alseres Pharmaceuticals Recent Development
Table 66. Cardinal Health Company Detail
Table 67. Cardinal Health Business Overview
Table 68. Cardinal Health Radiopharmaceutical Solutions Product
Table 69. Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 70. Cardinal Health Recent Development
Table 71. Jubilant Pharma Company Detail
Table 72. Jubilant Pharma Business Overview
Table 73. Jubilant Pharma Radiopharmaceutical Solutions Product
Table 74. Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 75. Jubilant Pharma Recent Development
Table 76. Central Research Laboratories Company Detail
Table 77. Central Research Laboratories Business Overview
Table 78. Central Research Laboratories Radiopharmaceutical Solutions Product
Table 79. Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 80. Central Research Laboratories Recent Development
Table 81. Cyclomedica Company Detail
Table 82. Cyclomedica Business Overview
Table 83. Cyclomedica Radiopharmaceutical Solutions Product
Table 84. Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 85. Cyclomedica Recent Development
Table 86. Bracco Company Detail
Table 87. Bracco Business Overview
Table 88. Bracco Radiopharmaceutical Solutions Product
Table 89. Bracco Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 90. Bracco Recent Development
Table 91. Eckert & Ziegler Radiopharma Company Detail
Table 92. Eckert & Ziegler Radiopharma Business Overview
Table 93. Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Product
Table 94. Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 95. Eckert & Ziegler Radiopharma Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiopharmaceutical Solutions Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Radiopharmaceutical Solutions Market Share by Type: 2022 VS 2033
Figure 3. Oral Tracking Features
Figure 4. Vein Tracking Features
Figure 5. Global Radiopharmaceutical Solutions Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Radiopharmaceutical Solutions Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Health Systems Case Studies
Figure 9. Others Case Studies
Figure 10. Radiopharmaceutical Solutions Report Years Considered
Figure 11. Global Radiopharmaceutical Solutions Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Radiopharmaceutical Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Radiopharmaceutical Solutions Market Share by Region: 2022 VS 2033
Figure 14. Global Radiopharmaceutical Solutions Market Share by Players in 2022
Figure 15. Global Top Radiopharmaceutical Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Radiopharmaceutical Solutions Revenue in 2022
Figure 17. North America Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 19. United States Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 23. Germany Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Radiopharmaceutical Solutions Market Share by Region (2018-2033)
Figure 31. China Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 39. Mexico Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 43. Turkey Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. IBA Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 46. GE Healthcare Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 47. Actinium Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 48. Alseres Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 49. Cardinal Health Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 50. Jubilant Pharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 51. Central Research Laboratories Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 52. Cyclomedica Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 53. Bracco Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 54. Eckert & Ziegler Radiopharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed